TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/24 06:01 | 8/9/24 | QSI | Quantum-Si Inc | DE | Electr | LabEq | Measuring & Controlling Devic | Kummeth Charles R. | CT | D | P.m | 148 | 0.8733 | 0 | 170 | 92 | 355 | D | |||||||||||||||
8/17/23 16:14 | 8/15/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | M.d | 0 | 0.00 | 0 | 18 | 1 | 1,279 | D | ||||||||||||||
8/8/23 17:31 | 8/5/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | M.d | 0 | 0.00 | 0 | 52 | 4 | 1,279 | D | ||||||||||||||
7/25/23 17:27 | 7/21/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | S.d | -7,069 | 88.36 | 0 | -80 | -6 | 1,260 | D | ||||||||||||||
7/5/23 18:38 | 6/30/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | M.d | 16,434 | 26.65 | 0 | 617 | 85 | 1,340 | D | ||||||||||||||
6/9/23 16:07 | 6/7/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | S.d | -27 | 83.00 | 0 | 0 | 0 | 1,114 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |